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Abstract: Although serum is a main source of essential nutrients and growth factors, its use creates
highly complex and poorly defined media. The use of serum-free media is more efficient than the use
of media containing serum especially when the purification and characterization of antibodies are
considered. In this study, we developed a serum-free medium system for cultivation of hybrid cells
producing monoclonal antibodies specific for Tobacco Mosaic Virus (1F5) and 17β-estradiol (10F4)
(15D4). Cells were cultivated in a medium with 10 % FCS for three days, and subsequently in serumfree medium for two days. The procedure was repeated once again providing monoclonal antibody in
the serum-free supernatants comparable in amounts and activity with that in serum containing media.
The method enabled purification of antibodies by a single step in high purity.
Key Words: Hybridoma technology, monoclonal antibody, 1F5 , 10F4, 15D4, ELISA, serum-free
medium, gel filtration chromotography

Monoklonal Antikorların Basit Bir Yöntemle Serumsuz
Besi Yerinde Üretilmesi ve Saflaştırılması
Özet: Serum hücreler için çok gerekli temel besi maddelerini ve büyüme faktörlerini içermesine
rağmen, serum kullanımı besi ortamının bileşiminin kompleks ve tanımlanamaz hale gelmesine neden
olur. Özellikle antikorların saflaştırılması ve karakterizasyonunda, serumsuz besi ortamı serumlu besi
yerinden daha etkilidir. Bu çalışmada Tütün Mozaik Virüsü (1F5) ve 17β-östradiol’e karşı geliştirilmiş
olan monoklonal antikorların (10F4), (15D4) serumsuz besi ortamında üretilebilmesi için bir yöntem
geliştirilmiştir. Bu amaçla hücreler önce 3 gün %10 serum içeren besi yerinde ve sonra 2 gün serumsuz
besi yerinde bekletildi. Aynı işlem bir kez daha tekrar edildi ve serumsuz besi ortamında elde edilen
monoklonal antikorların miktar ve aktivitesinin serumlu besi ortamından elde edilen sonuçlara
kıyaslanabilir olduğu görüldü. Bu yöntem monoklonal antikorların basit bir yöntem ile oldukça saf
olarak elde edilebilmesini sağlamıştır.
Anahtar Sözcükler: Hibridoma teknolojisi, monoklonal antikor, 1F5, 10F4, 15D4, ELISA, serumsuz
besi yeri, gel filtrasyon kromotografisi

Introduction
Monoclonal antibodies (mAbs) are homogeneous immunoglobulins synthesized by hybridoma
cells (1) and they have been widely used in immunodiagnostics and immunotherapy as well as
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in research because of their specificity for a single antigenic determinant of the target molecule
( 2, 3).
The necessity for large scale production of monoclonal antibodies for the immunodiagnostics
and therapeutics industry drives a part of research activities to develop low cost production
conditions, especially of new alternative culture media excluding the use of serum. Serum
protects the cells from environmental damage by providing enzymes and also alters physiological
/ physicochemical properties of the culture environment by coating surfaces with
macromolecules, buffer effect, surface tension and viscosity. While serum allows cell growth and
viability it contains uncharacterized elements and also its composition varies with the genetics,
dietary and the veterinary history of the individual animal from which it was obtained, thereby
necessitating periodic testing of different batches. Therefore, the addition of serum to a culture
medium makes its composition undefined and also leads to side effects in clinical applications
and finally to high costs.
Since one of the main objectives of work with hybridoma cells is the purification and
characterization of mAbs, it may be advantageous to avoid the use of serum to facilitate
purification. Serum-free media have been most often prepared by adding selected components
to basal nutrient media. These provide buffered, iso-osmotic, isotonic mixtures of vitamins,
amino acids, inorganic salts, glucose and other low molecular weight compounds. Methods for
the development of serum-free media have been improved by a variety of groups (4-6). In all
cases different additives (transferrin, insulin, lipoprotein, interleukins) at varying concentrations
are added to basal media. In that case, preparation of serum-free media is time consuming.
We report here the development of a cell cultivation method requiring very low amounts of
serum. It has been successfully used with three different hybridoma lines for production and
subsequent purification of the respective mAbs.
Materials and Methods
Myeloma cells and culture media
The myeloma cell line used for fusion was F0 (ATCC CRL 1646) and the culture medium
was Dulbecco’s modified Eagle’s medium (DMEM) (Life Technologies, Scotland). The culture
medium was supplemented with 10% (vol/vol) FCS (Seromed, Berlin) (20% (vol/vol) FCS
during fusion) and 2% HAT (Hypoxantine, Aminopterine, Thymidine) (later HT - Hypoxantine,
Thymidine) (Flow Laboratories, Scotland). All tissue culture flasks, 96- and 24-well polystrene
plates were from Nunc (Denmark).
Hybrid cells
Monoclonal antibody producing hybridoma cells were obtained using the classical fusion
procedure (7). One of the three mAbs (1F5) was specific for Tobacco Mosaic Virus (TMV) (8),
others (10F4), (15D4) (9) were specific for 17 β-estradiol.
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The specificity of 1F5 for TMV was determined by reacting 1F5 monoclonal antibody with
ToMV, PVX, PVY, CMV in an indirect ELISA system. 10F4 and 15D4 monoclonal antibodies
were, in turn, allowed to react with other closely related steroids such as progesterone,
aldosterone, testesterone, corticosterone at 200ng/well concentration in indirect ELISA (all the
steroids used were obtained in BSA-coupled form from the Sigma Chemical Company).
Subisotyping of antibodies
The immunoglobulin types of the three different antibodies were determined with a subisotyping kit system (Behring Diagnostics).
ELISA
Indirect ELISA was used for detecting antibody activity (10). For 1F5, a microtiter plate was
coated with 1µg TMV/well, and 200 ng Estradiol.BSA /well for 10F4 and 15D4 (32 mol.
Estradiol/mol.BSA). Alkaline phosphatase conjugated anti-mouse IgM (1/4000 dilution) (Sigma)
was the second enzyme. All incubations were performed at 37˚C, for 1 hour, and between
incubations, the wells were washed with PBS-Tween 20 three to four times.
Purification of mAbs
Monoclonal antibody produced in 5% FCS-containing and serum-free media was first
precipitated by ammonium sulfate, dialyzed and applied to a BioRad-gel filtration column (11).
Results
Cultivation strategy
Hybrid cells cultivated in medium containing 10% FCS were first transferred into medium
containing 5% FCS and then into serum-free medium. Antibody activity in cell supernatants was
screened for six days. The results indicated the inability of hybridoma cells to survive after the
second day when deprived of fresh medium.
The strategy developed for cultivation of the hybridoma cells in serum-free medium was,
therefore, as follows.
Cultivation of 1 x 107 hybrid cells in 175 cm2 flasks with DMEM containing 10% FCS for
three days, replacement by serum-free medium and cultivation for two days, replacement by 1
% FCS and cultivation for two days, finally replacement by serum-free medium and cultivation
for two days. (For each step, 100 ml DMEM was used).
In one set of experiments, supernatants with 10 % FCS (100 ml), 1 % FCS (100 ml), and
serum-free (total 200 ml) were collected in tubes and tested separately for antibody activity.
Three different hybrid cells were tested for productivity in this serum-free medium in parallel
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to controls maintained in 5% FCS containing medium. It was shown that the antibody activity
of three different hybrid cell lines were similar both in serum-free medium and in medium
containing 5% FCS (Figure 1).
Antibody purification
Hybridoma cells were cultured in 175 cm2 flasks in experimental and control conditions and
100ml supernatants were isolated in each case. Proteins in the supernatants precipitated with
ammonium sulfate were dissolved in 10 mM potassium phosphate buffer (PBS), and the
samples were subject to gel filtration using TSK 3000 SW G HPLC columns (LKB). The
amounts of both IgM and other protein components were far lower in serum-free
supernatants than in the medium containing 5% FCS (Figs 2 a, b). The concentration of purified
antibody from serum-free medium was 3.5 mg/l and 10.5 mg/l from medium containing 5%
serum due to contamination with unspecific antibodies and proteins from serum. When purified
antibodies were diluted and used in ELISA, dilutions of 1/400 for IgM (produced in serum-free
medium) and 1/600 for IgM (produced in 5 % FCS medium) gave rise to reactions of
equivalent intensity (Fig. 3). These results indicated that the mAbs obtained in serum-free
medium can allow efficient purification and reveal high titers.
Discussion
As has been extensively reviewed (12, 13) serum is an essential source for hormones,
growth factors and nutrient transporting molecules. However, the addition of serum to a culture
medium has some disadvantages especially when the maximal antibody purity and strict quality
are essential. One of the most obvious disadvantages is that high amounts of diverse proteins
are introduced into the system. Many of the contaminating proteins are immunoglobulins that
have similar properties to the antibody of interest. Consequently, purification of the antibody
from these protein mixtures is extremely difficult and always requires several additional steps.
Because of the inherent variability of serum, a purification protocol optimized for one lot of
serum may not be adequate for all batches of antibody. Moreover the use of animal sera
increases the risk of introducing infectious agents (such as viruses and mycoplasma) that may
compromise medical safety of the product in clinical use.
Although serum-free medium has been used successfully by a number of laboratories (1416) and also prepared and sold commercially, in all cases cultivation needs additional components
(e.g. transferrin, insulin and interleukin). So serum-free media are often more time consuming
to prepare than media containing serum; different additives with varying stabilities must be
purchased and prepared.
The serum requirements of some hybridoma cells may be reduced by maintaining the cells
at high density and antibody production is not proportional to the rate of cell proliferation,
rather it depends on the total number of cells in culture. In our experiments, confluent hybrid
cells revealed high levels of antibody synthesis in serum-free medium for two days and also
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TSK 3000 SW G column. Antibodies were eluted in 50 mM phosphate buffer-pH: 6.8 with a flow rate of
0.5 ml/min. After purification, all tubes were tested for antibody activity. After pooling of fractions with
antibody activity, IgM concentrations were calculated by the formula of “A280/1.18” (10).
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Comparison of antigen binding capacity of antibodies purified from 5 %FCS containing and serum-free
media.

after being fed in 1% serum containing medium, these cells continued antibody production
for two more days. Thus, one 175 cm2 flask gave rise to a total of 200 ml serum-free cell
culture supernatant with the antibody of interest as the main component. Purified antibody
yield from serum-free medium was, in turn, about one third of that from serum containing
medium. (3.5 mg/l versus 10.5 mg/l)
The superiority of the approach described here is that it does not necessitate the use of
serum or other components. Because of the absence of the other contaminating proteins and
especially immunoglobulins, antibody can be simply purified by single step ammonium sulfate
precipitation. The method which proved to be efficient in promoting the production of three
different mAbs, may provide an alternate for quick and cheap production and purification of
mAbs in laboratory scale. Moreover, this method could be similarly used for the production and
purification of other proteins of interest in a cell culture system.
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